Brain Scientific, Inc. · OTC:BRSF
Brain Scientific — Investor Presentation (January 2022)
15 slides from Brain Scientific's investor presentation, Jan 13, 2022
Slide 1: Investment Overview Jan 2022
Investment Overview Jan 2022 1
Slide 2: Legal Disclaimer
INVESTMENT OVERVIEW LEGAL DISCLAIMER THIS DOCUMENT HAS BEEN PREPARED FOR INFORMATIONAL PURPOSES ONLY . This document contains summary information about Brain Scientific Inc. (“Brain Scientific”). It does not purport to be complete, and no representations or warranties about such information are made
Slide 3: A MedTech Company: Breakthrough, Turnaround, Opportunity
A MEDTECH COMPANY Piezo Motion & Brain Scientific founded by researchers and career scientists The companies invested 20M+ in developing, refining and patenting the technologies but never commercialized BREAKTHROUGH Proven management team joins to commercialize and scale businesses Market strategy d
Slide 4: Total Addressable Market: EEG Devices and Motion Products
$2.0B $2.1B $2.2B $2.3B $2.4B $1.0B $1.1B $1.2B $1.3B $1.5B $3.0B $3.2B $3.4B $3.6B $3.9B 2021 2022 2023 2024 2025 We are selling into large, growing markets with a lot of potential for an innovative entrant Our disruptive solutions are poised to quickly expand in these markets EEG DEVICES MOTION PR
Slide 5: Disrupting Neurology: Hospital System Opportunity
DISRPUTING NEUROLOGY Hospital System Opportunity: • To date, the company has focused its sales efforts to hospitals only • AHA estimates only 30% of US hospitals have routine EEG equipment • In the US, twenty states have less than 10 Neurotechs to every 10,000 patients • Existing EEG systems are cos
Slide 6: Market Demand by Neurological Condition
ALZHEIMER’S DISEASE MILLION (USA) MILLION (USA) 795 THOUSAND (USA) 264 MILLION (GLOBALLY) MILLION (GLOBALLY) MILLION (USA) EPILEPSY SLEEP DISORDERS ADHD IN CHILDREN DEMENTIA DEPRESSION STROKE MIGRAINE MILLION (GLOBALLY) MILLION (GLOBALLY) MARKET DEMAND 5 2.5 50 6 6.1 30 50 50 - 70 MILLION (USA) TRAM
Slide 7: Untapped Markets
• Massive greenfield market opportunities • Aging population in need of more diagnostics • Wearables becoming widely adopted for monitoring • Neuro - telemedicine opening new untapped markets UNTAPPED MARKETS Pain Management Clinics Sleep Labs Nursing Homes Athletic Departments Mobile Clinics 7
Slide 8: Our Motion Products
LINEAR MOTORS Our linear and mini linear motors can be used to make an incision smaller than the human hair . ROTARY MOTORS Our rotary and mini rotary motors can be used to precisely dispense prescription drugs over a long period of time from a small battery. Market Opportunity: • Medical devices re
Slide 9: Disrupting Motion
DC Technology $140 • Limited precision • Complex control • Heavy materials • Many parts • High precision • Sophisticated controls • Heavy materials • Complex parts Conventional Piezo $1,200 Our Innovative MOTION TECHNOLOGY $120 • Precise • Simple to control • Lightweight materials • Few parts DISRUP
Slide 10: Microscope Stages, Micro Dosing Pump, Robotic Surgery
10 High precision, fast response and high speed make our linear motors an improved solution for automated microscope stages. In automated step, scan systems for analysis of large area, or multiplate samples, this enables throughput and productivity to be greatly improved. MICROSCOPE STAGES MICRO DOS
Slide 11: Untapped Markets: Infusion Pumps, MRI, Wearable Dispensers
Our motors can operate in high magnetic fields and provide motive power for devices such infusion pumps and ventilators where electromagnetic devices are impossible to use. INFUSION MRI PUMPS WEARABLE DISPENSERS Our motors offer power dense, lightweight and efficient motion with direct drive enablin
Slide 12: Intellectual Property
INTELLECTUAL PROPERTY 15 US Patents 25 World Patents 7 Trade Secrets 2 FDA Cleared Products (510k) 12
Slide 13: Hassan Kotob, Chairman & CEO
HASSAN KOTOB CHAIRMAN & CEO 29 years of experience bringing innovative technologies to the market, growing businesses, and creating significant shareholder value Founder and CEO of North Plains, a software solution that pioneered the market for enterprise digital asset management; sold to AKKR Presi
Slide 14: Proposed Financing
PROPOSED FINANCING Financing of up to $20M – $6M already secured Note converts at a price of $0.25 at uplist to NASDAQ, maturity (4/1/23), or voluntary conversion Convertible promissory note with 10% interest plus 50% warrant coverage issued at uplist to NASDAQ or maturity Warrants convertible at $0
Slide 15: Thank You
Investment Overview Jan 2022 Thank You 15
Brain Scientific — Investor Presentation (January 2022) on 6ix